Aclarion, Inc. ( (ACON) ) just unveiled an update. Aclarion, Inc. announced the pricing of a registered direct offering of ...

Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market 03.01.2025 / 22:15 CET/CEST The issuer is solely ...

Aclarion, Inc. (NASDAQ: ACON) recently disclosed the outcomes of its 2024 Annual Meeting of Stockholders in a Form 8-K filing with the Securities and Exchange Commission. The meeting, which took place ...

Aclarion, Inc. announced the termination of its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC effective immediately. This decision halts the company’s ability to ...

BROOMFIELD, CO - (NewMediaWire) - January 3, 2025 - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW ...

Aclarion, Inc., a Delaware-incorporated medical laboratories service provider, announced the results of its annual stockholders meeting held on December 31, 2024. The meeting saw the election of ...

Over the last year, Aclarion share price has been traded in a range of 0.285, hitting a high of 0.3869, and a low of 0.1019. Aclarion is listed on the CBOE trading with ticker code ACON.US.

Aclarion, Inc. (NASDAQ:ACON), a medical laboratory services provider, has terminated its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC, effective immediately.

Aclarion, Inc. (NASDAQ:ACON), a medical laboratory services provider, has terminated its At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC, effective immediately. The ...